In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MIV Therapeutics Inc.

Latest From MIV Therapeutics Inc.

The Future of Drug-Eluting Stents Part I: Novel Next-Generation Designs

Growth by innovation is almost considered a birthright in interventional cardiology, and based on presentations at this year's Transcatheter Cardiovascular Therapeutics meeting, held this September in San Francisco, it seems clear that innovation still reigns supreme in this specialty. However, as in other medical device markets, ongoing economic and regulatory pressures are taking their toll, particularly in the drug-eluting stent market, as the field adjusts to a new era of cost control and economic uncertainty.

Medical Device

Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q3 2007

In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.

BioPharmaceutical Medical Device

Deals Update (09/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device

Dealmaking Roundup March 2007

Summary of recent device mergers and acquisitions, alliances, and financings.

Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Infusion Therapy Equipment and Supplies
  • Other Names / Subsidiaries
    • MIVI Technologies
UsernamePublicRestriction

Register